147 related articles for article (PubMed ID: 31430896)
1. EGFR-c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells.
Kwak SM; Seo J; Hwang JT; Sung GJ; Song JH; Jeong JH; Lee SH; Yoon HG; Choi HK; Choi KC
Cells; 2019 Aug; 8(8):. PubMed ID: 31430896
[TBL] [Abstract][Full Text] [Related]
2. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
Mueller KL; Hunter LA; Ethier SP; Boerner JL
Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
[TBL] [Abstract][Full Text] [Related]
3. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.
Kloth MT; Laughlin KK; Biscardi JS; Boerner JL; Parsons SJ; Silva CM
J Biol Chem; 2003 Jan; 278(3):1671-9. PubMed ID: 12429742
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells.
Biscardi JS; Belsches AP; Parsons SJ
Mol Carcinog; 1998 Apr; 21(4):261-72. PubMed ID: 9585256
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of HDAC3 by Src kinase mediates proliferation of HER2-positive breast cancer cells.
Seo J; Guk G; Park SH; Jeong MH; Jeong JH; Yoon HG; Choi KC
J Cell Physiol; 2019 May; 234(5):6428-6436. PubMed ID: 30317579
[TBL] [Abstract][Full Text] [Related]
6. EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells.
Moiseeva EP; Heukers R; Manson MM
Carcinogenesis; 2007 Feb; 28(2):435-45. PubMed ID: 16956907
[TBL] [Abstract][Full Text] [Related]
7. c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tumor cells.
Matteucci E; Ridolfi E; Maroni P; Bendinelli P; Desiderio MA
Mol Cancer Res; 2007 Aug; 5(8):833-45. PubMed ID: 17699109
[TBL] [Abstract][Full Text] [Related]
8. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
[TBL] [Abstract][Full Text] [Related]
10. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2832-9. PubMed ID: 16799022
[TBL] [Abstract][Full Text] [Related]
11. Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation.
Miyake T; Parsons SJ
Oncogene; 2012 Mar; 31(11):1431-41. PubMed ID: 21822308
[TBL] [Abstract][Full Text] [Related]
12. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
[TBL] [Abstract][Full Text] [Related]
13. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
Tan M; Li P; Sun M; Yin G; Yu D
Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
[TBL] [Abstract][Full Text] [Related]
14. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
Lombardo CR; Consler TG; Kassel DB
Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
[TBL] [Abstract][Full Text] [Related]
15. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
16. Involvement of pp60c-src with two major signaling pathways in human breast cancer.
Luttrell DK; Lee A; Lansing TJ; Crosby RM; Jung KD; Willard D; Luther M; Rodriguez M; Berman J; Gilmer TM
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):83-7. PubMed ID: 7506422
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms involved in epidermal growth factor receptor-mediated inhibition of dopamine D
Sun N; Zhang X; Guo S; Le HT; Zhang X; Kim KM
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1187-1200. PubMed ID: 29885323
[TBL] [Abstract][Full Text] [Related]
18. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.
Faivre EJ; Lange CA
Mol Cell Biol; 2007 Jan; 27(2):466-80. PubMed ID: 17074804
[TBL] [Abstract][Full Text] [Related]
20. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
